Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer

Objective To explore the effectiveness of synthetic MRI sequences in predicting the treatment response of patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy treatment (nCRT). Methods A total of 51 patients with biopsy-confirmed rectal adenocarcinoma were enr...

Full description

Saved in:
Bibliographic Details
Main Author: WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
Format: Article
Language:zho
Published: Editorial Office of Journal of Diagnostics Concepts & Practice 2025-04-01
Series:Zhenduanxue lilun yu shijian
Subjects:
Online Access:https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188812722-1865754580.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233848381997056
author WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
author_facet WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
author_sort WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
collection DOAJ
description Objective To explore the effectiveness of synthetic MRI sequences in predicting the treatment response of patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy treatment (nCRT). Methods A total of 51 patients with biopsy-confirmed rectal adenocarcinoma were enrolled at Ruijin Hospital from August 2023 to June 2024. All patients were assessed as having LARC by baseline MRI and received nCRT followed by radical surgery. All subjects completed synthetic MRI and high-resolution T2-weighted imaging (T2WI) scans within two weeks before receiving nCRT treatment. Based on high-resolution T2WI images, radiologists assessed extramural vascular invasion (mrEMVI) at baseline in the subjects. After the synthetic MRI sequence scanning was completed, synthetic images of T1 mapping, T2 mapping, and proton density (PD) mapping were generated using Synthetic MR post-processing software. Histogram-based quantitative parameters at baseline were extracted using python software, including quantitative parame-ters of the primary tumor and peritumoral fat region: T1 relaxation time (T1RT), T2 relaxation time (T2RT), and proton density (PD). Using postoperative pathological results as the gold standard, patients were grouped according to: (1) primary tumor response: pathological complete response (pCR) vs. non-pCR; (2) tumor regression grade: (TRG) 0-1 vs. TRG 2-3; and (3) mesorectal lymph node metastasis status: positive (ypN+) vs. negative (ypN-). Differences in baseline mrEMVI status and quantitative parameters of the primary tumor and peritumoral fat among different groups were compared using Student's t-test, Mann-Whitney U test, and Chi-square test. Binary logistic regression was used to identify independent risk factors for predicting TRG grade, pCR status, and mesorectal lymph node status. Based on the selected risk factors, logistic regression models were established. The predictive performance of the quantitative parameters, mrEMVI status, and the regression models for TRG grade, pCR status, and mesorectal lymph node status was evaluated using receiver operating characteristic (ROC) curves. Results Baseline mrEMVI positivity (P=0.03) and quantitative parameters of peritumoral fat tissue-including the maximum T2RT_Fat (139.53 ms vs. 129.60 ms, P=0.03), 90th percentile (189.18 ms vs. 174.00 ms, P=0.03), root mean square (120.09 ms vs. 115.48 ms, P=0.04), and lower T2RT_Fat uniformity (0.54 vs. 0.61, P=0.04)—were indicative of positive mesorectal lymph node status after nCRT. None of the observed indicators were correlated with the primary tumor response. Logistic regression analysis showed that mrEMVI and elevated T2RT_Fat_P90 were independent risk factors for predicting mesorectal lymph node metastasis. The logistic regression model combining both mrEMVI (AUC=0.667) and T2RT_Fat_P90 (AUC=0.692) demonstrated good predictive performance (AUC=0.747), although the improvement was not statistically significant. Conclusions T2RT_Fat_P90, extracted from baseline MAGiC synthetic MRI serves as a non-invasive imaging biomarker for predicting mesorectal lymph node metastasis after nCRT. The combination of T2RT_Fat_P90 and baseline mrEMVI can be used as an auxiliary tool for predicting the mesorectal lymph node metastasis status in LARC patients following nCRT.
format Article
id doaj-art-6c07db81af6f4b4288fb97b4e9db0077
institution Kabale University
issn 1671-2870
language zho
publishDate 2025-04-01
publisher Editorial Office of Journal of Diagnostics Concepts & Practice
record_format Article
series Zhenduanxue lilun yu shijian
spelling doaj-art-6c07db81af6f4b4288fb97b4e9db00772025-08-20T04:03:22ZzhoEditorial Office of Journal of Diagnostics Concepts & PracticeZhenduanxue lilun yu shijian1671-28702025-04-01240217017710.16150/j.1671-2870.2025.02.008Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancerWANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan0Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaObjective To explore the effectiveness of synthetic MRI sequences in predicting the treatment response of patients with locally advanced rectal cancer (LARC) undergoing neoadjuvant chemoradiotherapy treatment (nCRT). Methods A total of 51 patients with biopsy-confirmed rectal adenocarcinoma were enrolled at Ruijin Hospital from August 2023 to June 2024. All patients were assessed as having LARC by baseline MRI and received nCRT followed by radical surgery. All subjects completed synthetic MRI and high-resolution T2-weighted imaging (T2WI) scans within two weeks before receiving nCRT treatment. Based on high-resolution T2WI images, radiologists assessed extramural vascular invasion (mrEMVI) at baseline in the subjects. After the synthetic MRI sequence scanning was completed, synthetic images of T1 mapping, T2 mapping, and proton density (PD) mapping were generated using Synthetic MR post-processing software. Histogram-based quantitative parameters at baseline were extracted using python software, including quantitative parame-ters of the primary tumor and peritumoral fat region: T1 relaxation time (T1RT), T2 relaxation time (T2RT), and proton density (PD). Using postoperative pathological results as the gold standard, patients were grouped according to: (1) primary tumor response: pathological complete response (pCR) vs. non-pCR; (2) tumor regression grade: (TRG) 0-1 vs. TRG 2-3; and (3) mesorectal lymph node metastasis status: positive (ypN+) vs. negative (ypN-). Differences in baseline mrEMVI status and quantitative parameters of the primary tumor and peritumoral fat among different groups were compared using Student's t-test, Mann-Whitney U test, and Chi-square test. Binary logistic regression was used to identify independent risk factors for predicting TRG grade, pCR status, and mesorectal lymph node status. Based on the selected risk factors, logistic regression models were established. The predictive performance of the quantitative parameters, mrEMVI status, and the regression models for TRG grade, pCR status, and mesorectal lymph node status was evaluated using receiver operating characteristic (ROC) curves. Results Baseline mrEMVI positivity (P=0.03) and quantitative parameters of peritumoral fat tissue-including the maximum T2RT_Fat (139.53 ms vs. 129.60 ms, P=0.03), 90th percentile (189.18 ms vs. 174.00 ms, P=0.03), root mean square (120.09 ms vs. 115.48 ms, P=0.04), and lower T2RT_Fat uniformity (0.54 vs. 0.61, P=0.04)—were indicative of positive mesorectal lymph node status after nCRT. None of the observed indicators were correlated with the primary tumor response. Logistic regression analysis showed that mrEMVI and elevated T2RT_Fat_P90 were independent risk factors for predicting mesorectal lymph node metastasis. The logistic regression model combining both mrEMVI (AUC=0.667) and T2RT_Fat_P90 (AUC=0.692) demonstrated good predictive performance (AUC=0.747), although the improvement was not statistically significant. Conclusions T2RT_Fat_P90, extracted from baseline MAGiC synthetic MRI serves as a non-invasive imaging biomarker for predicting mesorectal lymph node metastasis after nCRT. The combination of T2RT_Fat_P90 and baseline mrEMVI can be used as an auxiliary tool for predicting the mesorectal lymph node metastasis status in LARC patients following nCRT.https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188812722-1865754580.pdf|rectal cancer|lymph node metastasis|magnetic resonance imaging|neoadjuvant chemoradiotherapy
spellingShingle WANG Kangning, ZHU Lan, FENG Weiming, XIA Yihan, SHI Bowen, ZHANG Huan
Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
Zhenduanxue lilun yu shijian
|rectal cancer|lymph node metastasis|magnetic resonance imaging|neoadjuvant chemoradiotherapy
title Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
title_full Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
title_fullStr Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
title_full_unstemmed Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
title_short Value of synthetic MRI in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
title_sort value of synthetic mri in predicting treatment response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
topic |rectal cancer|lymph node metastasis|magnetic resonance imaging|neoadjuvant chemoradiotherapy
url https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188812722-1865754580.pdf
work_keys_str_mv AT wangkangningzhulanfengweimingxiayihanshibowenzhanghuan valueofsyntheticmriinpredictingtreatmentresponsetoneoadjuvantchemoradiotherapyinpatientswithlocallyadvancedrectalcancer